Recent Advances on Cerium Oxide-Based Biomaterials: Toward the Next Generation of Intelligent Theranostics Platforms.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 37314429.
- Also identified by DOI 10.1002/adhm.202300748.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Disease or organ damage due to unhealthy living habits, or accidents, is inevitable. Discovering an efficient strategy to address these problems is urgently needed in the clinic. In recent years, the biological applications of nanotechnology have received extensive attention. Among them, as a widely used rare earth oxide, cerium oxide (CeO<sub>2</sub> ) has shown good application prospects in biomedical fields due to its attractive physical and chemical properties. Here, the enzyme-like mechanism of CeO<sub>2</sub> is elucidated, and the latest research progress in the biomedical field is reviewed. At the nanoscale, Ce ions in CeO<sub>2</sub> can be reversibly converted between +3 and +4. The conversion process is accompanied by the generation and elimination of oxygen vacancies, which give CeO<sub>2</sub> the performance of dual redox properties. This property facilitates nano-CeO<sub>2</sub> to catalyze the scavenging of excess free radicals in organisms, hence providing a possibility for the treatment of oxidative stress diseases such as diabetic foot, arthritis, degenerative neurological diseases, and cancer. In addition, relying on its excellent catalytic properties, customizable life-signaling factor detectors based on electrochemical techniques are developed. At the end of this review, an outlook on the opportunities and challenges of CeO<sub>2</sub> in various fields is provided.
Medical subject headings
- Cerium
- Nanoparticles